Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer.
Vera P, Giraud P, Hapdey S, Gouel P, Jan O, Le Roux P, Langlais A, Lévêque E, Le Tinier F, Olivier A, Martin E, Berriolo-Riedinger A, Pourel N, Broglia JM, Boisselier P, Guillemard S, Salem N, Brenot-Rossi I, Garcia C, Berthold C, Giroux-Leprieur E, Moreau D, Guillerm S, Benali K, Tessonnier L, Audigier-Valette C, Lerouge D, Quak E, Massabeau C, Courbon F, Loo M, Larrouy A, Ghazzar N, Chaumet-Riffaud P, Amour E, Zalcman G, Modzelewski R, Thureau S.
Vera P, et al. Among authors: ghazzar n.
J Nucl Med. 2025 Apr 1;66(4):516-524. doi: 10.2967/jnumed.124.268499.
J Nucl Med. 2025.
PMID: 40015915
Clinical Trial.